Ovarian Cancer-Associated Ascites Have High Proportions of Cytokine-Responsive CD56bright NK Cells

Cells. 2021 Jul 6;10(7):1702. doi: 10.3390/cells10071702.

Abstract

Ovarian cancer is the most lethal gynecological malignancy, with serous histotype as the most prevalent epithelial ovarian cancer (EOC). Peritoneal ascites is a frequent comorbidity in advanced EOC. EOC-associated ascites provide a reliable sampling source for studying lymphocytes directly from tumor environment. Herein, we carried out flow cytometry-based analysis to readdress issues on NK and T lymphocyte subsets in women with advanced EOC, additionally evaluating phenotypic modulation of their intracellular pathways involved in interleukin (IL)-2 and IL-15 signaling. Results depicted ascites as an inflammatory and immunosuppressive environment, presenting significantly (p < 0.0001) higher amounts of IL-6 and IL-10 than in the patients' blood, as well as significantly (p < 0.05) increased expression of checkpoint inhibitory receptors (programmed death protein-1, PD-1) and ectonucleotidase (CD39) on T lymphocytes. However, NK lymphocytes from EOC-associated ascites showed higher (p < 0.05) pS6 phosphorylation compared with NK from blood. Additionally, in vitro treatment of lymphocytes with IL-2 or IL-15 elicited significantly (p < 0.001) phosphorylation of the STAT5 protein in NK, CD3 and CD8 lymphocytes, both from blood and ascites. EOC-associated ascites had a significantly (p < 0.0001) higher proportion of NK CD56bright lymphocytes than blood, which, in addition, were more responsive (p < 0.05) to stimulation by IL-2 than CD56dim NK. EOC-associated ascites allow studies on lymphocyte phenotype modulation in the tumor environment, where inflammatory profile contrasts with the presence of immunosuppressive elements and development of cellular self-regulating mechanisms.

Keywords: STAT5; cytotoxic lymphocytes; ectonucleotidases; inhibitory checkpoint receptor; pS6; tumor microenvironment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Apyrase / genetics
  • Apyrase / immunology
  • Ascites / genetics
  • Ascites / immunology*
  • Ascites / pathology
  • CD56 Antigen / genetics
  • CD56 Antigen / immunology*
  • Cystadenocarcinoma, Serous / genetics
  • Cystadenocarcinoma, Serous / immunology*
  • Cystadenocarcinoma, Serous / pathology
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunophenotyping
  • Interleukin-10 / genetics
  • Interleukin-10 / immunology
  • Interleukin-15 / genetics
  • Interleukin-15 / immunology
  • Interleukin-2 / genetics
  • Interleukin-2 / immunology
  • Interleukin-6 / genetics
  • Interleukin-6 / immunology
  • K562 Cells
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / pathology
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Staging
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / immunology*
  • Ovarian Neoplasms / pathology
  • Programmed Cell Death 1 Receptor / genetics
  • Programmed Cell Death 1 Receptor / immunology
  • STAT5 Transcription Factor / genetics
  • STAT5 Transcription Factor / immunology
  • Signal Transduction
  • T-Lymphocytes / immunology
  • T-Lymphocytes / pathology
  • Tumor Microenvironment / genetics
  • Tumor Microenvironment / immunology

Substances

  • CD56 Antigen
  • IL10 protein, human
  • IL15 protein, human
  • IL6 protein, human
  • Interleukin-15
  • Interleukin-2
  • Interleukin-6
  • NCAM1 protein, human
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • STAT5 Transcription Factor
  • Interleukin-10
  • Apyrase
  • ENTPD1 protein, human